News
Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...
Mersana Therapeutics Inc. (NASDAQ: MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana Therapeutics presented additional positive interim Phase 1 clinical data for ...
The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...
Positive interim Phase 2 results evaluating the safety and efficacy of SSGJ-707 as monotherapy in patients with advanced NSCLC were recently presented at the American Society of Clinical Oncology ...
Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...
Nearly one-third of patients with pancreatic cancer missed germline testing, with the disparities tied to race, insurance, and care setting.
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
ASCO convened a panel of experts to update the clinical guidelines for fertility preservation in men, women, and adolescents with cancer.
ASCO 2025 showcased breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results